New study seeks immune clues to prevent HCMV transmission in pregnancy
NCT ID NCT07477925
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is looking for immune system markers that might predict whether a pregnant woman with a first-time HCMV infection will pass the virus to her unborn baby. Researchers will study blood samples from 90 pregnant women and their newborns to see which immune responses are linked to lower transmission risk. The goal is to develop a test that helps doctors better assess risk and guide care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN CYTOMEGALOVIRUS (HCMV) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione IRCCS Policlinico San Matteo
RECRUITINGPavia, Lombardy, 27100, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••